| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/29/2008 | US7365077 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | US7365052 Tendon-inducing methods |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364764 Soluble roasted chicory having high inulin content |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |
| 04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
| 04/29/2008 | CA2283572C Bifurcated method to process aloe whole leaf |
| 04/29/2008 | CA2245484C Novel urea derivatives |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/25/2008 | CA2602078A1 Acute and chronic heartburn composition and method |
| 04/24/2008 | WO2008047983A1 Composition for preventing and treating inflammatory bowel diseases |
| 04/24/2008 | WO2008047863A1 Sustained release preparation for tissue regeneration therapy |
| 04/24/2008 | WO2008047853A1 Prophylactic/therapeutic agent for gastroesophageal reflux disease |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 04/24/2008 | WO2008047663A1 Activity enhancer for detoxifying enzyme |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics |
| 04/24/2008 | WO2007133721A3 Food compositions and methods of treating periodontal disease |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096971 Treatment of Inflammatory Disorders and Pain |
| 04/24/2008 | US20080096967 Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into Animals |
| 04/24/2008 | US20080096960 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096925 Analgesics for neuropathy, surgery, nervous system disorders, headaches, arthritis, psoriasis, respiratory system disorders, and gastrointestinal disorders; ethyl 4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-1-piperidinecarboxylate; |
| 04/24/2008 | US20080096895 Heterocyclic Derivatives and Their Use as Stearoyl-Coa Desaturase Inhibitors |
| 04/24/2008 | US20080096890 Highly Selective Norepinephrine Reuptake Inhibitors and Methods of Using the Same |
| 04/24/2008 | US20080096888 Novel compounds as opioid receptor modulators |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096854 Orally administering edible oil homogenized with edible wax and a sterol comprising stigmasterol, campesterol, p-sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and poriferasterol to treat colorectal, stomach, and/or esophagus cancer |
| 04/24/2008 | US20080096849 Administering balsalazide with food increases bioavailability of balsalazide and metabolites 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid; label on container recommends to take drug with food; inflammatory bowel disease, radiation enteritis, colon cancer; gastrointestinal disorders |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080095868 Use of fermented wheat-germ in the feeding and veterinary practice |
| 04/24/2008 | US20080095860 Layer of submucosa, basement membrane, and mucosa; disrupt cells in tumor; apply matrix as liquid or semi-solid, a sheet or a particulate; recruitment of an endogenous stem cell to site; inhibition of abnormally proliferating malignant cells |
| 04/24/2008 | US20080095858 Detecting restriction fragment length polymorphisms associated with liver disorders; multidrug resistance gene (MDR) |
| 04/24/2008 | US20080095853 Modified Release For Proton Pump Inhibitors |
| 04/24/2008 | US20080095839 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax |
| 04/24/2008 | US20080095800 Eliciting HCV-specific antibodies |
| 04/24/2008 | US20080095766 Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095745 Transgenic butyrivibrio fibrisolvens for use in treatment and prevention of infections, allergic and inflammatory bowel disease |
| 04/24/2008 | CA2667039A1 Multiple unit tablet compositions of benzimidazole compounds |
| 04/23/2008 | EP1913944A1 Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 04/23/2008 | EP1913940A1 Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis |
| 04/23/2008 | EP1913001A2 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 04/23/2008 | EP1912947A1 Isotopically substituted pantoprazole |
| 04/23/2008 | EP1912658A1 Therapeutic protocols using hyaluronan |
| 04/23/2008 | EP1497269B1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1418860B1 Oral care substance delivery strip |
| 04/23/2008 | EP1372673B1 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 04/23/2008 | EP1251824B1 Use of a beverage composition comprising a polyphosphate for treating dental erosion |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101165160A Method for producing health care wine |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164612A Traditional Chinese medicine for treating infantile vomiting milk |
| 04/23/2008 | CN101164595A Traditional Chinese medicine for curing anorexia |
| 04/23/2008 | CN101164582A Traditional Chinese medicine for treating infantile mycotic enteritis |
| 04/23/2008 | CN101164580A Plaster for treating enterogastric disease |
| 04/23/2008 | CN101164577A Heat-clearing fire-evil-dispelling and summer-passing summerheat-relieving summer-passing tea |
| 04/23/2008 | CN101164573A Traditional Chinese medicine for treating cold stagnation infantile hernia |
| 04/23/2008 | CN101164572A Orally-administered medicine for treating hepatitis B virus |
| 04/23/2008 | CN101164569A Heat clearing stone eliminating and stone dissolving decoction |
| 04/23/2008 | CN101164551A Optimization formula for liver cancer-resisting traditional Chinese medicine active ingredient |
| 04/23/2008 | CN101164537A High-efficient oral silibinin sustained-release preparation and preparation method thereof |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100382845C Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure |
| 04/23/2008 | CN100382827C Chinese medicine for treating colonitis |
| 04/23/2008 | CN100382814C Chinese medicine preparation for invigorating liver and kidney and its preparing method |
| 04/23/2008 | CN100382804C Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 04/23/2008 | CN100382801C Pharmaceutical use of alpha-(2,4-dichlorobenzyle)-1H-imidazole-1-ethanol for treating hepatitis |
| 04/23/2008 | CN100382800C Bifendate solid dispersible, and its preparing method and low-release preparation containing same |
| 04/23/2008 | CN100382799C Power for intravenous injection with liver-protecting action, and its preparation and quality control method |
| 04/23/2008 | CN100382787C Quick acting toothache relieving dripping pills and its preparation method |
| 04/23/2008 | CN100382715C Herbal tea and preparation method thereof |
| 04/23/2008 | CN100382710C Preparation method of digestive and Yiwei milk powder with micro-meter Huaguoshan and golden monkey sugar |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361684 Screening of compounds for treatment of atherosclerosis and heart attack |
| 04/22/2008 | US7361668 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |